Erratum

Yeung J, Holinstat M. Newer agents in antiplatelet therapy: a review. Journal of Blood Medicine. 2012;3:33–42.An error was made on page 37, section GPVI receptor antagonists, in the above paper. The company currently moving Revacept through clinical development is in fact advanceCor GmbH (Martinsried, Germany) and not ABX-CRO/Medifacts GmbH (Goerlitz, Saxony, Germany).Read the original article.